Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 7,469Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Lo Loestrin

02 3Myfembree/Ryeqo

PharmaCompass

03

04

Brand Name : Lo Loestrin

arrow
American Pharma Summit
Not Confirmed

Norethindrone Acetate/Ethinyl Estradiol

Main Therapeutic Indication : Sexual Health

Currency : USD

2018 Revenue in Millions : 528

2017 Revenue in Millions : 459

Growth (%) : 15%

Abbvie CB

05

06

Brand Name : Lo Loestrin

arrow
American Pharma Summit
Not Confirmed

Norethindrone Acetate

Main Therapeutic Indication : Urology

Currency : USD

2019 Revenue in Millions : 589

2018 Revenue in Millions : 528

Growth (%) : 12

Abbvie CB

07

Brand Name : Myfembree/Ryeqo

Norethisterone Acetate

arrow
American Pharma Summit
Not Confirmed

Brand Name : Myfembree/Ryeqo

arrow
American Pharma Summit
Not Confirmed

Norethisterone Acetate

Main Therapeutic Indication : Women's Healthcare

Currency : USD

2021 Revenue in Millions : 8

2020 Revenue in Millions : 0

Growth (%) : New Launch in 2021

blank

08

Brand Name : Myfembree/Ryeqo

Norethisterone Acetate

arrow
American Pharma Summit
Not Confirmed

Brand Name : Myfembree/Ryeqo

arrow
American Pharma Summit
Not Confirmed

Norethisterone Acetate

Main Therapeutic Indication : Women's Health

Currency : USD

2022 Revenue in Millions : 25

2021 Revenue in Millions : 8

Growth (%) : 234

blank

09

Brand Name : Myfembree/Ryeqo

Norethisterone Acetate

arrow
American Pharma Summit
Not Confirmed

Brand Name : Myfembree/Ryeqo

arrow
American Pharma Summit
Not Confirmed

Norethisterone Acetate

Main Therapeutic Indication : Women's Health

Currency : USD

2023 Revenue in Millions : 60

2022 Revenue in Millions : 32

Growth (%) : 110

blank